Approvals/NMPA/Recombinant Human Tumor Necrosis Factor-α ReceptorⅡ:IgG Fc Fusion Protein for Injection

Approved

生物制品

Recombinant Human Tumor Necrosis Factor-α ReceptorⅡ:IgG Fc Fusion Protein for Injection

上海赛金生物医药有限公司🇨🇳 National Medical Products Administration

Approval Id: 7LeafrRVcKS
Approval Number: 国药准字S20110004
Generic Name: 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白
Generic Name En: Recombinant Human Tumor Necrosis Factor-α ReceptorⅡ:IgG Fc Fusion Protein for Injection
Brand Name: 强克
Drug Type: 生物制品
Dosage Form: 注射剂(无菌粉末)
Strength: 25mg/瓶
Reg Date: 2020-08-13
Company Name: 上海赛金生物医药有限公司
Production Company Name: 上海赛金生物医药有限公司
Production Company Address: 中国（上海）自由贸易试验区春晓路300号
Company Detail Path: /organization/shang-hai-sai-jin-sheng-wu-yi-yao-you-xian-gong-si
Production Company Detail Path: /organization/shang-hai-sai-jin-sheng-wu-yi-yao-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Aug 13, 2020

Approval ID

7LeafrRVcKS

Type

生物制品